Perry, Marielle <br/><br/>
FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid Leukemia.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  12 2018 
 - e545-e550 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2018.06.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Biomarkers, Tumor<br/>Combined Modality Therapy<br/>Cytogenetic Analysis<br/>Female<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--diagnosis<br/>Male<br/>Middle Aged<br/>Mutation<br/>Nuclear Proteins--genetics<br/>Nucleophosmin<br/>Prognosis<br/>Protein Interaction Domains and Motifs--genetics<br/>Retrospective Studies<br/>Tandem Repeat Sequences<br/>Treatment Outcome<br/>Young Adult<br/>fms-Like Tyrosine Kinase 3--antagonists & inhibitors